Brainstorm cell therapeutics to announce second quarter results and provide a corporate update

New york , aug. 7, 2024 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it will hold a conference call to update shareholders on financial results for the second quarter ended june 30, 2024, and provide a corporate update, at 8:30 a.m. eastern time on wednesday, august 14, 2024.
BCLI Ratings Summary
BCLI Quant Ranking